Publications by Truls Erik Bjerklund Johansen
60 publications found
Original articles
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol
Int J Antimicrob Agents, 62 (5), 106974
DOI 10.1016/j.ijantimicag.2023.106974, PubMed 37739241
Non-Antibiotic Prophylaxis for Recurrent UTIs in Neurogenic Lower Urinary Tract Dysfunction (NAPRUN): Study Protocol for a Prospective, Longitudinal Multi-Arm Observational Study
Methods Protoc, 6 (3)
DOI 10.3390/mps6030052, PubMed 37367996
Artificial Intelligence Can Guide Antibiotic Choice in Recurrent UTIs and Become an Important Aid to Improve Antimicrobial Stewardship
Antibiotics (Basel), 12 (2)
DOI 10.3390/antibiotics12020375, PubMed 36830285
Practice Patterns in Fournier's Gangrene in Europe and Implications for a Prospective Registry Study
Antibiotics (Basel), 12 (2)
DOI 10.3390/antibiotics12020197, PubMed 36830108
A Proposal of a New Nomogram to Predict the Need for Testosterone ReplACEment (TRACE): A Simple Tool for Everyday Clinical Practice
J Pers Med, 12 (10)
DOI 10.3390/jpm12101654, PubMed 36294793
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
World J Urol, 39 (9), 3433-3440
DOI 10.1007/s00345-020-03580-7, PubMed 33442769
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
Urol Oncol, 39 (3), 197.e9-197.e17
DOI 10.1016/j.urolonc.2020.12.005, PubMed 33397593
Birt-Hogg-Dube-syndrome
Tidsskr. Nor. Laegeforen., 140 (6), 565-569
[Birt-Hogg-Dubé syndrome]
Tidsskr Nor Laegeforen, 140 (6)
DOI 10.4045/tidsskr.18.0848, PubMed 32321218
Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
Int J Antimicrob Agents, 56 (1), 105935
DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620
Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
World J Urol, 38 (1), 27-34
DOI 10.1007/s00345-019-02963-9, PubMed 31555835
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol, 38 (1), 17-26
DOI 10.1007/s00345-019-02837-0, PubMed 31183524
Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
Acta Radiol, 60 (9), 1175-1180
DOI 10.1177/0284185118813709, PubMed 30450921
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
Urology, 99, 100-105
DOI 10.1016/j.urology.2016.10.016, PubMed 27773650
Treatment of Urinary Tract Infections and Antibiotic Stewardship
Eur. Urol. Suppl., 15 (4), 81-87
DOI 10.1016/j.eursup.2016.04.003
Management of Uncomplicated Recurrent Urinary Tract Infections
Eur. Urol. Suppl., 15 (4), 95-101
DOI 10.1016/j.eursup.2016.04.007
Management of the Urologic Sepsis Syndrome
Eur. Urol. Suppl., 15 (4), 102-111
DOI 10.1016/j.eursup.2016.04.004
Improved Classification of Urinary Tract Infection: Future Considerations
Eur. Urol. Suppl., 15 (4), 71-80
DOI 10.1016/j.eursup.2016.04.002
Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
Eur. Urol. Suppl., 15 (4), 112-121
DOI 10.1016/j.eursup.2016.04.001
The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections
Pathogens, 5 (1)
DOI 10.3390/pathogens5010010, PubMed 26797640
Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013
World J Urol, 34 (8), 1193-200
DOI 10.1007/s00345-015-1722-1, PubMed 26658886
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831
Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates
Eur J Radiol, 80 (2), 553-8
DOI 10.1016/j.ejrad.2011.01.109, PubMed 21353753
[Hormone treatment of prostate cancer in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2558-62
PubMed 19023350
[PSA based screening for prostatic cancer]
Tidsskr Nor Laegeforen, 128 (22), 2612-4
PubMed 19023357
Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
Scand J Urol Nephrol, 41 (2), 124-31
DOI 10.1080/00365590600911266, PubMed 17454951
Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies
Int J Antimicrob Agents, 28 Suppl 1, S91-107
DOI 10.1016/j.ijantimicag.2006.05.005, PubMed 16829052
[Cryotherapy for prostate cancer]
Tidsskr Nor Laegeforen, 125 (12), 1661-3
PubMed 15976835
EAU guidelines for the management of genitourinary tuberculosis
Eur Urol, 48 (3), 353-62
DOI 10.1016/j.eururo.2005.03.008, PubMed 15982799
The role of imaging in urinary tract infections
World J Urol, 22 (5), 392-8
DOI 10.1007/s00345-004-0414-z, PubMed 15290204
Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urology
Int J Antimicrob Agents, 23 Suppl 1, S30-4
DOI 10.1016/j.ijantimicag.2003.09.003, PubMed 15037326
[Drugs against urinary incontinence]
Tidsskr Nor Laegeforen, 123 (2), 178-9
PubMed 12607502
[Drugs against symptomatic, benign prostatic hyperplasia]
Tidsskr Nor Laegeforen, 122 (26), 2544-5
PubMed 12522881
Review articles
Antimicrobial Prophylaxis in Robot-Assisted Laparoscopic Radical Prostatectomy: A Systematic Review
Antibiotics (Basel), 12 (12)
DOI 10.3390/antibiotics12121744, PubMed 38136777
Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
Curr Opin Urol, 27 (2), 107-111
DOI 10.1097/MOU.0000000000000368, PubMed 27906777
A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
Rev Urol, 19 (4), 213-220
DOI 10.3909/riu0780, PubMed 29472825
An update on prevention and treatment of catheter-associated urinary tract infections
Curr Opin Infect Dis, 27 (1), 102-7
DOI 10.1097/QCO.0000000000000031, PubMed 24345923
Reducing infection rates after prostate biopsy
Nat Rev Urol, 11 (2), 80-6
DOI 10.1038/nrurol.2013.322, PubMed 24418806
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
Int J Antimicrob Agents, 38 Suppl, 64-70
DOI 10.1016/j.ijantimicag.2011.09.009, PubMed 22018988
Contemporary results of focal therapy for prostate cancer using cryoablation
J Endourol, 24 (5), 827-34
DOI 10.1089/end.2009.0546, PubMed 20443724
[Radical therapy for prostate cancer in Norway]
Tidsskr Nor Laegeforen, 125 (12), 1658-60
PubMed 15976834
Other articles
[Not Available]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.23.0531, PubMed 37668126
[Not Available]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.23.0529, PubMed 37668128
[Is it better not to perform a PSA test?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0248, PubMed 37254991
Facing urosepsis- the most deadly of all urological diseases
Scand J Urol, 56 (5-6), 421-422
DOI 10.1080/21681805.2022.2137230, PubMed 36314558
Pregnant women should be screened for asymptomatic bacteriuria
Tidsskr. Nor. Laegeforen., 141 (11), 1046-1048
[Pregnant women should be screened for asymptomatic bacteriuria]
Tidsskr Nor Laegeforen, 141 (11)
DOI 10.4045/tidsskr.21.0379, PubMed 34423934
Rescue treatment for cancer
Tidsskr. Nor. Laegeforen., 141 (5), 487
Working on a Dream
Eur. Urol. Suppl., 15 (4), 69-70
DOI 10.1016/j.eursup.2016.04.006
How to Use Antimicrobial Prophylaxis in Urological Procedures
Eur Urol Focus, 2 (4), 348-350
DOI 10.1016/j.euf.2016.02.010, PubMed 28723464
[Re: The problematical prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1536
DOI 10.4045/tidsskr.15.0915, PubMed 26394580
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1535-6
DOI 10.4045/tidsskr.15.0928, PubMed 26394579
[Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (10), 924-5
DOI 10.4045/tidsskr.15.0317, PubMed 26037750
Urinary Tract Infections
Antibiotics (Basel), 3 (3), 375-7
DOI 10.3390/antibiotics3030375, PubMed 27025751
Reliable diagnostic work-up of rare urinary infections
Tidsskr Nor Laegeforen, 134 (5), 533
DOI 10.4045/tidsskr.13.1198, PubMed 24621913
Antimicrobial therapy of urinary tract infections
Int J Antimicrob Agents, 38 Suppl, 1-2
DOI 10.1016/j.ijantimicag.2011.09.001, PubMed 22018987
[A public disease without guidelines]
Tidsskr Nor Laegeforen, 123 (17), 2410
PubMed 14508529
[Renal cancer in a 20-year perspective]
Tidsskr Nor Laegeforen, 122 (25), 2430
PubMed 12448108
[Ritual circumcision]
Tidsskr Nor Laegeforen, 122 (1), 15
PubMed 11851285